Moshe Orenstein, Chief Compliance Officer of Nayax Ltd., filed a Form 3 initial statement of beneficial ownership with the SEC on October 30, 2026, reporting his holdings as of October 5, 2026, the date he became subject to Section 16 reporting requirements.

Key Highlights

  • Reporting Person: Moshe Orenstein, identified as CCO of Nayax Ltd. (NASDAQ:NYAX), filed an initial beneficial ownership statement triggered by his becoming subject to Section 16 reporting as of October 5, 2026.
  • Direct Ordinary Share Holdings: Orenstein directly owns six separate lots of ordinary shares totaling 20,982 shares, including 4,325 shares held on the Tel Aviv Stock Exchange.
  • RSU Grants: Orenstein holds four separate RSU grants covering 953, 1,049, 1,623, and 10,000 units, with varying vesting schedules extending through June 3, 2029 for the longest tranche.
  • Stock Options: Orenstein holds two tranches of stock options, each for 5,000 ordinary shares, with an exercise price of $38.1074 (denominated in New Israeli Shekels at the grant-date exchange rate), both expiring February 17, 2027.
  • Vested Options: One tranche of 5,000 options is fully vested and immediately exercisable; of the second tranche, 4,500 are vested and 500 vest on December 31, 2026, subject to continued service.
  • Filing Agent: The form was signed by Meirav Shemesh on behalf of Oppenheimer Israel, as attorney-in-fact, on October 30, 2026.

Orenstein's Reported Holdings in Nayax Ltd. as of October 5, 2026

According to the filing, Moshe Orenstein holds ordinary shares of Nayax Ltd. across six direct positions. One lot of 4,325 shares is noted as being held on the Tel Aviv Stock Exchange, while a separate lot of 3,032 shares carries no such notation. The remaining four positions consist of RSU grants covering 953, 1,049, 1,623, and 10,000 units, all representing contingent rights to receive one ordinary share each upon vesting.

The filing details distinct vesting schedules for each RSU grant. The 953-unit grant has 302 RSUs already vested, with 651 remaining to vest in three equal quarterly installments from December 26, 2026 through June 26, 2027. The 1,049-unit grant has 174 RSUs vested, with 875 vesting in seven equal quarterly installments from December 25, 2026 through June 25, 2028. The 1,623-unit grant has 355 vested, with 1,268 vesting in eleven equal quarterly installments from December 3, 2026 through June 3, 2029. The 10,000-unit grant specifies 2,000 RSUs vesting on March 15, 2027, with the remaining 8,000 vesting in four equal annual installments over the following four years. All RSU vesting is subject to the reporting person's continued service to Nayax or its subsidiaries.

In Table II, the filing reports two derivative security positions. Both are stock options with an exercise price of $38.1074, described as denominated in New Israeli Shekels with the U.S. dollar figure reflecting the grant-date exchange rate, and both expire on February 17, 2027. The first tranche of 5,000 options became exercisable November 17, 2022, and is fully vested. The second tranche of 5,000 options, exercisable beginning September 30, 2024, has 4,500 vested options currently exercisable and 500 options that vest on December 31, 2026, contingent on continued service.

What Was Disclosed

Moshe Orenstein, CCO of Nayax Ltd., filed an initial Form 3 disclosing direct ownership of ordinary shares and derivative securities as of October 5, 2026, the date he became subject to Section 16 reporting requirements under the Securities Exchange Act of 1934.